David Delgado

935 total citations
14 papers, 294 citations indexed

About

David Delgado is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, David Delgado has authored 14 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in Genetics. Recurrent topics in David Delgado's work include Hematopoietic Stem Cell Transplantation (6 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Music Therapy and Health (3 papers). David Delgado is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Music Therapy and Health (3 papers). David Delgado collaborates with scholars based in United States, Australia and Denmark. David Delgado's co-authors include Kenneth B. DeSantes, David Lorentzen, Jill Kolesar, Paul M. Sondel, John M. Maris, KyungMann Kim, Jacquelyn A. Hank, Songwon Seo, Wendy B. London and Richard K. Yang and has published in prestigious journals such as Blood, Cancer Research and Frontiers in Psychology.

In The Last Decade

David Delgado

12 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Delgado United States 8 123 114 101 74 64 14 294
M J Watts United Kingdom 10 72 0.6× 141 1.2× 199 2.0× 24 0.3× 44 0.7× 14 391
Erin H. Breese United States 10 52 0.4× 83 0.7× 109 1.1× 36 0.5× 17 0.3× 26 297
Magnus Sabel Sweden 10 65 0.5× 52 0.5× 60 0.6× 67 0.9× 181 2.8× 20 394
Sitaram Ghogale India 12 40 0.3× 95 0.8× 174 1.7× 19 0.3× 51 0.8× 29 320
Mena Farag United Kingdom 9 103 0.8× 49 0.4× 90 0.9× 17 0.2× 203 3.2× 28 414
Agostino Nozzolillo Italy 10 60 0.5× 60 0.5× 25 0.2× 109 1.5× 47 0.7× 20 310
Melita Kenealy Australia 10 35 0.3× 69 0.6× 132 1.3× 10 0.1× 109 1.7× 20 269
Kimon V. Argyropoulos United States 10 75 0.6× 45 0.4× 27 0.3× 12 0.2× 44 0.7× 25 268
H. Becker Germany 13 163 1.3× 166 1.5× 55 0.5× 6 0.1× 34 0.5× 38 473
Helen M. Clark United States 8 49 0.4× 171 1.5× 24 0.2× 21 0.3× 60 0.9× 13 380

Countries citing papers authored by David Delgado

Since Specialization
Citations

This map shows the geographic impact of David Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Delgado more than expected).

Fields of papers citing papers by David Delgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Delgado. The network helps show where David Delgado may publish in the future.

Co-authorship network of co-authors of David Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of David Delgado. A scholar is included among the top collaborators of David Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Delgado. David Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Robb, Sheri L., Kristin Stegenga, Susan M. Perkins, et al.. (2023). Mediators and Moderators of Active Music Engagement to Reduce Traumatic Stress Symptoms and Improve Well-being in Parents of Young Children With Cancer. Integrative Cancer Therapies. 22. 1563533402–1563533402. 7 indexed citations
2.
Holochwost, Steven J., Susan M. Perkins, Kristin Stegenga, et al.. (2020). Cortisol as an Acute Stress Biomarker in Young Hematopoietic Cell Transplant Patients/Caregivers: Active Music Engagement Protocol. The Journal of Alternative and Complementary Medicine. 26(5). 424–434. 7 indexed citations
3.
Holochwost, Steven J., Sheri L. Robb, Kristin Stegenga, et al.. (2020). Active Music Engagement and Cortisol as an Acute Stress Biomarker in Young Hematopoietic Stem Cell Transplant Patients and Caregivers: Results of a Single Case Design Pilot Study. Frontiers in Psychology. 11. 587871–587871. 8 indexed citations
4.
Schamberger, Marcus S., David Delgado, Jodi Skiles, et al.. (2020). Successful Allogeneic Stem Cell Transplant in Pediatric Patients With Diminished Left Ventricular Ejection Fractions. Journal of Pediatric Hematology/Oncology. 42(8). e788–e790. 1 indexed citations
5.
Levis, Mark J., Mehdi Hamadani, Brent R. Logan, et al.. (2019). BMT CTN Protocol 1506: A Phase 3 Trial of Gilteritinib As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with FLT3-ITD+ AML. Blood. 134(Supplement_1). 4602–4602. 25 indexed citations
6.
Gabriel, Melissa, Bronwen E. Shaw, Ruta Brazauskas, et al.. (2017). Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). Biology of Blood and Marrow Transplantation. 23(8). 1320–1326. 5 indexed citations
7.
Abraham, Allistair, Andrew Cluster, David A. Jacobsohn, et al.. (2017). Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial. Biology of Blood and Marrow Transplantation. 23(9). 1587–1592. 50 indexed citations
8.
Abraham, Allistair, Andrew Cluster, David A. Jacobsohn, et al.. (2017). Successful engraftment but high viral reactivation after reduced intensity unrelated umbilical cord blood transplantation for sickle cell disease. Cytotherapy. 19(5). S8–S8.
9.
Farag, Sherif S., Robert P. Nelson, Mitchell S. Cairo, et al.. (2017). High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation. Oncotarget. 8(66). 110350–110357. 28 indexed citations
10.
Abraham, Allistair, Andrew Cluster, David A. Jacobsohn, et al.. (2017). Reduced Intensity Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease: Results of a Phase I Trial. Biology of Blood and Marrow Transplantation. 23(3). S73–S73.
11.
Hege, Kerry, Troy C. Quigg, & David Delgado. (2015). Alemtuzumab, Fludarabine, Low‐Dose TBI, and Double Umbilical Cord Transplant for Primary Graft Failure in a Patient with Recurrent HLH. Pediatric Blood & Cancer. 63(2). 361–363. 4 indexed citations
12.
Delgado, David, Daniel E. Webster, Kenneth B. DeSantes, Emily T. Durkin, & Aimen F. Shaaban. (2010). KIR receptor‐ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cells. Pediatric Blood & Cancer. 55(7). 1300–1305. 22 indexed citations
13.
Delgado, David, Jacquelyn A. Hank, Jill Kolesar, et al.. (2010). Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy. Cancer Research. 70(23). 9554–9561. 136 indexed citations
14.
Delgado, David, et al.. (2007). KIR Incompatible NK Cells Effectively Lyse Osteosarcoma Cells.. Blood. 110(11). 4905–4905. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026